T2 biosystems

In a trial that involved over 1,500 patients at seven hospitals, the device correctly identified 91 percent of the people who had a candida infection. This led to the U.S. Food and Drug Administration's taking just three months-record time for a new technology-to approve T2's instrument and candida test.